Article Details
Retrieved on: 2022-10-20 12:11:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
VectorBuilder Biotechnology (Guangzhou) Co., Ltd., a Hong Kong-based gene delivery company, raised CNY410M in Series C funding.
Article found on: www.finsmes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here